Format

Send to:

Choose Destination
See comment in PubMed Commons below
Trends Pharmacol Sci. 2004 Nov;25(11):592-600.

Pharmacological interventions in ventilator-induced lung injury.

Author information

  • 1Division of Pulmonary Pharmacology, Research Center Borstel, Leibniz-Center for Medicine and Biosciences, Borstel, Germany. suhlig@fz-borstel.de

Abstract

During mechanical ventilation the lungs are exposed to substantial physical forces. This is particularly true for patients with acute lung injury, where the applied pressures are two to three times higher than those present during normal breathing. The resultant overdistension activates specific mechanotransduction pathways, many of which activate inflammation pathways that might lead to (further) acute lung injury. In this article, we review evidence suggesting that pharmacological strategies can interfere with ventilator-induced lung injury at different stages of the inflammatory cascade: blockade of transcription factors, neutralization of chemokines, cytokines and neuropeptides, and inhibition of proteases. These findings provide rationale for the use of anti-inflammatory therapies to treat the side-effects of mechanical ventilation.

PMID:
15491782
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk